These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 31370000)

  • 21. Genetic Characteristics of Incidental Pheochromocytoma and Paraganglioma.
    Zhang J; Li M; Pang Y; Wang C; Wu J; Cheng Z; Li X; Lu Z; Liu Y; Guo J; Chen X; He Y; Guan X; Xu X; Wang Y; Liu J; Guo W; Hou Y; Liu L; Jiang J; Gao X
    J Clin Endocrinol Metab; 2022 Apr; 107(5):e1835-e1842. PubMed ID: 35106577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disentangling of Malignancy from Benign Pheochromocytomas/Paragangliomas.
    Kim KY; Kim JH; Hong AR; Seong MW; Lee KE; Kim SJ; Kim SW; Shin CS; Kim SY
    PLoS One; 2016; 11(12):e0168413. PubMed ID: 27992508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosing phaeochromocytoma/paraganglioma in a patient presenting with critical illness: biochemistry versus imaging.
    Amar L; Eisenhofer G
    Clin Endocrinol (Oxf); 2015 Sep; 83(3):298-302. PubMed ID: 25683095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Naloxone provokes catecholamine release in phaeochromocytomas and paragangliomas.
    Bouloux PM; Grossman A; Besser GM
    Clin Endocrinol (Oxf); 1986 Mar; 24(3):319-25. PubMed ID: 3708878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology and Prognosis of Pheochromocytoma/Paraganglioma in Korea: A Nationwide Study Based on the National Health Insurance Service.
    Kim JH; Moon H; Noh J; Lee J; Kim SG
    Endocrinol Metab (Seoul); 2020 Mar; 35(1):157-164. PubMed ID: 32207276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation Between Plasma Catecholamines, Weight, and Diabetes in Pheochromocytoma and Paraganglioma.
    Krumeich LN; Cucchiara AJ; Nathanson KL; Kelz RR; Fishbein L; Fraker DL; Roses RE; Cohen DL; Wachtel H
    J Clin Endocrinol Metab; 2021 Sep; 106(10):e4028-e4038. PubMed ID: 34089611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of pheochromocytomas and abdominal and pelvic paragangliomas with head and neck paragangliomas.
    Al-Harthy M; Al-Harthy S; Al-Otieschan A; Velagapudi S; Alzahrani AS
    Endocr Pract; 2009 Apr; 15(3):194-202. PubMed ID: 19364686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonselective Compared With Selective α-Blockade Is Associated With Less Intraoperative Hypertension in Patients With Pheochromocytomas and Paragangliomas: A Retrospective Cohort Study With Propensity Score Matching.
    Kong H; Li N; Yang XC; Nie XL; Tian J; Wang DX
    Anesth Analg; 2021 Jan; 132(1):140-149. PubMed ID: 32675634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glycemic disorders in patients with pheochromocytomas and sympathetic paragangliomas.
    Araujo-Castro M; Mínguez Ojeda C; García Centeno R; López-García MC; Lamas C; Hanzu FA; Mora M; Del Castillo Tous M; Rodríguez de Vera Gómez P; Parra Ramírez P; Alvarez-Escola C; Blanco Carrera C; Barahona San Millán R; Recasens M; Valdés N; Gracia Gimeno P; de Miguel Novoa P; Vicente A; Manjón L; García Sanz I; Michalopoulou T; Calatayud M
    Endocr Relat Cancer; 2022 Dec; 29(12):645-655. PubMed ID: 36069783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk Factors for Cardiac Complications in Patients With Pheochromocytoma and Paraganglioma: A Retrospective Single-Center Study.
    Zhao L; Meng X; Mei Q; Fan H; Liu Y; Zhou X; Zhu H; Zhang S
    Front Endocrinol (Lausanne); 2022; 13():877341. PubMed ID: 35721724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The clinical characteristics of patients with normotension in pheochromocytomas and paragangliomas.
    Zhao L; Zhang T; Meng X; Fan H; Zhang Z; Liu Y; Zhou X; Zhu H
    Endocrine; 2023 Apr; 80(1):174-182. PubMed ID: 36749542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pheochromocytomas and Hypertension.
    Pappachan JM; Tun NN; Arunagirinathan G; Sodi R; Hanna FWF
    Curr Hypertens Rep; 2018 Jan; 20(1):3. PubMed ID: 29356966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of epigenetic regulation on catecholamine synthesis in pheochromocytoma and paraganglioma.
    Kaplinsky A; Halperin R; Shlomai G; Tirosh A
    Cancer; 2024 Oct; 130(19):3289-3296. PubMed ID: 38872410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma.
    Eisenhofer G; Pacak K; Huynh TT; Qin N; Bratslavsky G; Linehan WM; Mannelli M; Friberg P; Grebe SK; Timmers HJ; Bornstein SR; Lenders JW
    Endocr Relat Cancer; 2011 Feb; 18(1):97-111. PubMed ID: 21051559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosis for Pheochromocytoma and Paraganglioma: A Joint Position Statement of the Korean Pheochromocytoma and Paraganglioma Task Force.
    Ku EJ; Kim KJ; Kim JH; Kim MK; Ahn CH; Lee KA; Lee SH; Lee YB; Park KH; Choi YM; Hong N; Hong AR; Kang SW; Park BK; Seong MW; Kim M; Jung KC; Jung CK; Cho YS; Paeng JC; Kim JH; Ryu OH; Rhee Y; Kim CH; Lee EJ
    Endocrinol Metab (Seoul); 2021 Apr; 36(2):322-338. PubMed ID: 33820394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of plasma metanephrines measured by a commercial immunoassay and urinary catecholamines in the diagnosis of pheochromocytoma.
    Christensen TT; Frystyk J; Poulsen PL
    Scand J Clin Lab Invest; 2011 Dec; 71(8):695-700. PubMed ID: 22023043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for pheochromocytomas and paragangliomas.
    Eisenhofer G
    Curr Hypertens Rep; 2012 Apr; 14(2):130-7. PubMed ID: 22258313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Performance of plasma fractionated free metanephrines by enzyme immunoassay in the diagnosis of pheochromocytoma and paraganglioma.
    Sarathi V; Pandit R; Jagtap V; Lila AR; Bandgar TR; Menon PS; Varthakavi P; Raghavan VP; Shah NS
    Endocr Pract; 2011; 17(5):759-65. PubMed ID: 21742610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pheochromocytoma and paraganglioma: An emerging cause of secondary osteoporosis.
    Yokomoto-Umakoshi M; Umakoshi H; Fukumoto T; Matsuda Y; Nagata H; Ogata M; Kawate H; Miyazawa T; Sakamoto R; Ogawa Y;
    Bone; 2020 Apr; 133():115221. PubMed ID: 31940499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High specificity of spot urinary free metanephrines in diagnosis and prognosis of pheochromocytomas and paragangliomas by HPLC with electrochemical detection.
    Zuo M; Zhen Q; Zhang X; Zou W; Yang X; Tian G; Shi Z; Li Q; Ding M
    Clin Chim Acta; 2018 Mar; 478():82-89. PubMed ID: 29273559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.